Evidence map›Paper›PMID 40585837›Full record

ReviewWorld journal of clinical oncology2025

Inclusion criteria for liver transplantation in patients with colorectal liver metastases: How to make the best selection?

Maja Cigrovski Berkovic, Anna Mrzljak, Fabio Melandro, Quirino Lai

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maja Cigrovski BerkovicDepartment for Sport and Exercise Medicine, University of Zagreb Faculty of Kinesiology, Zagreb 10000, Croatia. maja.cigrovskiberkovic@gmail.com.
Anna MrzljakDepartment of Gastroenterology and Hepatology, University Hospital Centre Zagreb, Zagreb 10000, Croatia.
Fabio MelandroTransplant Unit, Sapienza University of Rome, Rome 00161, Italy.
Quirino LaiGeneral Surgery and Organ Transplantation Unit, Department of Surgery, Sapienza University of Rome, Rome 00018, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The selection of patients with colorectal cancer liver metastases (CRLM) for liver transplantation (LT) represents a significant challenge, requiring a balance between oncological outcomes and organ scarcity. Recent advancements in transplantation outcomes for CRLM have prompted the establishment of rigorous selection criteria to optimize patient survival and graft utilization. This review examines the key criteria used to select candidates for LT in this setting, with a focus on oncological factors, patient characteristics, and response to therapy. Eligible candidates are typically those with non-resectable liver-only CRLM, demonstrating controlled primary tumor disease. Tumor biology is a critical determinant, excluding patients exhibiting high-risk molecular features such as

Indexed as

Colorectal carcinomaDonor characteristicsLiver metastasesLiver transplantationOutcomesRecipient characteristics

Identifiers

PMID40585837
PMCPMC12198860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.